The present invention comprises certain quinoline lactams of formula I; pharmaceutically acceptable salts of the compounds of formula I; pharmaceutical compositions containing a compound of formula I, or a pharmaceutically acceptable salt thereof, for use in the treatment of anxiety; and processes for the manufacture of the compounds of formula I, as well as intermediates for use in such manufacture.
本发明涉及公式I的某些
喹啉内酰胺;公式I化合物的药学上可接受的盐;含有公式I化合物或其药学上可接受的盐的药物组合物,用于治疗焦虑症;以及制备公式I化合物的过程,以及用于此类制备的中间体。